文献速递脑血管病

实验性缺血性卒中诱导的α-突触核蛋白病理增强内皮炎症反应并损害血管新生

Experimental Ischemic Stroke-Induced Alpha-Synuclein Pathology Enhances Endothelial Inflammatory Response and Impairs Angiogenesis.
PubMed 文献 · Stroke · 2025-09-18

该研究在小鼠短暂性局灶性脑缺血模型中探究缺血诱导的α-突触核蛋白(α-Syn)病理对血管炎症和血管新生的影响。α-Syn缺失小鼠亚急性期功能恢复更好且生存率更高,急性期内皮炎症和免疫细胞浸润减少,亚急性期促血管新生因子和血管新生的血管上调。体外实验显示重组α-Syn可上调脑微血管内皮细胞ICAM-1、IL-6和VEGFR-2表达。

要点

  • 脑缺血诱导α-Syn基因表达和寡聚化增加,并定位于缺血皮层血管周围。
  • α-Syn缺失改善亚急性期功能恢复和生存,减轻急性期内皮炎症和免疫浸润。
  • α-Syn缺失促进亚急性期血管新生,重组α-Syn直接上调内皮炎症和血管新生相关分子。

核心结论

  • 缺血触发的病理性α-Syn通过促进急性期内皮炎症反应和免疫细胞浸润、限制亚急性期血管新生,导致卒中小鼠结局更差。

研究设计与样本

  • 在C57BL/6J野生型和C57BL/6Sα-Syn自发缺失小鼠中诱导短暂性局灶性脑缺血,共72只小鼠随机接受假手术(12只)或缺血(60只),基因型按1:1分配。
  • 缺血小鼠纳入标准为出现≥3个缺血期局灶性神经功能缺损,实验终点为再灌注48小时(急性期)和7天(亚急性期)。
  • 结局指标包括感觉运动评估、高架十字迷宫和生存分析,脑样本用于qRT-PCR、Western blot和免疫组化,体外采用脑微血管内皮细胞缺血模型研究细胞外α-Syn的直接效应。

主要发现

  • 体内脑缺血诱导α-Syn基因表达2.5倍变化,蛋白寡聚化2.7至3.2倍变化,明显定位于皮层缺血血管周围。
  • C57BL/6Sα-Syn缺失缺血小鼠亚急性期功能恢复改善且生存更好(至终点87%),而C57BL/6J缺血小鼠生存为45%。
  • α-Syn缺失小鼠急性期ICAM-1、MMP-9和血管通透性因子表达降低,伴浸润白细胞和血管周围小胶质细胞减少。
  • α-Syn缺失小鼠亚急性期促血管新生因子(VEGF-A、VEGFR-2、Angpt-2和IL-6)及血管新生的血管上调。
  • 体外脑微血管内皮细胞在缺血开始时暴露于重组α-Syn可上调ICAM-1、IL-6和VEGFR-2表达,α-Syn在缺氧条件下预适应18小时后效应更大。

临床怎么用

  • 在卒中急性期,靶向病理性α-Syn可能减轻内皮炎症反应和免疫细胞浸润。
  • 在亚急性期,促进α-Syn清除或抑制其病理可能有助于血管新生和功能恢复。

局限性

  • 研究为探索性临床前小鼠实验,样本量有限,结论需进一步验证。
  • α-Syn缺失为全身性自发删除,无法区分血管内皮与其他细胞来源的效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: α-Syn (alpha-synuclein) increases and oligomerization contributes to ischemic brain damage. Nevertheless, the exact mechanisms of ischemia-induced α-Syn pathology after stroke are understudied. In this exploratory and hypothesis-testing study, we specifically investigated how ischemia-induced α-Syn pathology impacts vascular inflammation and angiogenesis. METHODS: Transient focal cerebral ischemia was induced in C57BL/6J wild-type and C57BL/6S mice with spontaneous deletion of α-Syn. In total, 72 mice were randomized to receive sham (12) or ischemia (60), with 1:1 allocation to genotype. Ischemic mice were included if presenting ≥3 intraischemic focal deficits. Experimental end points were 48 hours (acute phase) and 7 days (subacute phase) of reperfusion. Sensorimotor assessment, elevated plus maze, and survival analysis were stroke outcome readouts. Brain samples were collected for quantitative real-time polymerase chain reaction, Western blot, and immunohistochemistry. In vitro ischemia in brain microvascular endothelial cells was used to investigate the direct effect of extracellular α-Syn. RESULTS: In vivo, cerebral ischemia induced α-Syn 2.5-fold change gene expression, 2.7- to 3.2-fold-change protein oligomerization with apparent localization around cortical ischemic vessels. Improved subacute functional recovery linked to better survival was observed in C57BL/6S α-Syn null (87% to end point) versus C57BL/6J (45%) ischemic mice. The α-Syn null mice had reduced expression of ICAM-1, MMP-9, and vascular permeability factors, associated with less infiltrating leukocytes and juxta-vascular microglia in the acute phase. In the subacute phase, they showed upregulated proangiogenic factors (VEGF-A, VEGFR-2, Angpt-2, and IL-6) and angiogenic vessels. In vitro, brain microvascular endothelial cells upregulated ICAM-1, IL-6, and VEGFR-2 expression when exposed to recombinant α-Syn at the beginning of ischemia and to a larger extent when α-Syn was preconditioned for 18 hours in hypoxia. CONCLUSIONS: These findings indicate that ischemia-triggered pathological α-Syn leads to worse outcome in stroke mice by promoting endothelial inflammatory response and immune cell infiltration during the acute phase and by limiting angiogenesis in the subacute phase.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Bogale TA, Mercurio D, Valente A, et al. Experimental Ischemic Stroke-Induced Alpha-Synuclein Pathology Enhances Endothelial Inflammatory Response and Impairs Angiogenesis. Stroke. 2025. PMID: 40964705. doi:10.1161/STROKEAHA.125.052265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。